Zeria Pharmaceutical Co., Ltd. (TYO:4559)
2,016.00
+34.00 (1.72%)
Sep 14, 2026, 3:30 PM JST
Zeria Pharmaceutical Market Cap
Zeria Pharmaceutical has a market cap or net worth of 88.86 billion as of September 11, 2026. Its market cap has decreased by -4.09% in one year.
Market Cap
88.86B
Enterprise Value
97.87B
Revenue
91.12B
Ranking
n/a
PE Ratio
10.80
Stock Price
2,016.00
ChartMarket Cap Chart
Since December 22, 1998, Zeria Pharmaceutical's market cap has increased from 58.12B to 88.86B, an increase of 52.91%. That is a compound annual growth rate of 1.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 88.86B | -3.95% |
| Dec 30, 2025 | 92.52B | -14.05% |
| Dec 30, 2024 | 107.64B | 21.07% |
| Dec 29, 2023 | 88.91B | -11.00% |
| Dec 30, 2022 | 99.90B | 12.78% |
| Dec 30, 2021 | 88.58B | 0.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nippon Shinyaku | 228.22B |
| Sawai Group Holdings | 182.53B |
| Towa Pharmaceutical | 173.28B |
| Kissei Pharmaceutical | 165.39B |
| Kaken Pharmaceutical | 145.04B |
| Mochida Pharmaceutical | 111.43B |
| KYORIN Pharmaceutical | 62.67B |
| ASKA Pharmaceutical Holdings | 57.93B |